CSYZ:XETRA Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD

EUR 100.92 0.00 0
Icon

Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD (CSYZ:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 100.92

0.00 (0.00)%

EUR 0.22B

6.00

EUR -1.00

N/A

Icon

CSYZ:XETRA

Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD (EUR)
ETF | XETRA
EUR 100.92
0.00 0
Take a Tour

Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD (CSYZ:XETRA) Stock Forecast

N/A

Based on the Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD stock forecast from 0 analysts, the average analyst target price for Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD is not available over the next 12 months. Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD’s stock price was EUR 100.92. Credit Suisse Index Fund (IE) ETF ICAV - CSIF (IE) FTSE EPRA Nareit Developed Grn Bl UCITS ETF B USD’s stock price has changed by +1.29% over the past week, +0.14% over the past month and +3.47% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...